PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8780041-6	1996	Moreover, cerebrocortical NPY-ir was reduced in rats receiving treatment with pargyline, an inhibitor of monoamine oxidase, with an elevation of catecholamine in parallel.	Pargyline	78-87	neuropeptide Y	Rattus norvegicus	26-29	
8945753-0	1996	Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment.	Pargyline	122-131	neuropeptide Y	Rattus norvegicus	61-75	
8945753-0	1996	Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment.	Pargyline	122-131	neuropeptide Y	Rattus norvegicus	77-80	
8945753-4	1996	Values of NPY-like immunoreactivity (NPY-ir) were reduced in rats receiving the treatment of pargyline, the inhibitor of monoamine oxidase, with an elevation of catecholamine in parallel.	Pargyline	93-102	neuropeptide Y	Rattus norvegicus	10-13	
8945753-4	1996	Values of NPY-like immunoreactivity (NPY-ir) were reduced in rats receiving the treatment of pargyline, the inhibitor of monoamine oxidase, with an elevation of catecholamine in parallel.	Pargyline	93-102	neuropeptide Y	Rattus norvegicus	37-40